AwardedPRTGoodsFramework agreement€288,045
INIBIDORES DE TIROSINASINACES – OSIMERTINIB - 3 MESES
- Published
- Published 17 June 2026
Overview
Serviços de Saúde da Região Autónoma da Madeira procured a three-month supply of tyrosine kinase inhibitors (osimertinib) for pharmaceutical use. The contract was awarded on 1 June 2026 to ASTRAZENECA PRODUTOS FARMACEUTICOS, LDA for a value of €288,045.12.
Key details
- Country
- PRT
- Status
- Awarded
- Category
- Goods
- Estimated value
- €288,045
- Procedure
- Selective
- Contract type
- Framework agreement
- Published
- 17 June 2026
Pharmaceutical productsVarious medicinal products
Award outcome
- Awarded value
- €288,045
- Award date
- 1 June 2026
- Contract period
- — → 30 August 2026
- ASTRAZENECA PRODUTOS FARMACEUTICOS, LDA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
17 June 2026
Contracting authority
Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)
Procuring entityFunchal, PRT
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.